1Calabresi P,Centonze D,Bernardi G.Cellular factors controlling neuronal vulnerability in the brain:a lesson from the striatum.Neurology,2000,55:1249-1255.
2Artru AA,Michenfelder JD.Cerebral protective metabolic,and vascular effccts of phenytoin.Stroke,1980,11:377.
3Cullen JP,Aldrete JA,Jankovsky L,et al.Protective action of phenytoin in cerebral ischemia.Anesth Analg(Cleve),1979,58:165.
4Edmonds HL Jr,Jiang YD,Zhang PY,et al.Topiramate as a neuroprotectant in a rat modelof global ischemia-induced neurodegeneration.Life Sci,2001,69:2265-2277.
7Zador Z,Benyo Z,Lacza Z,et al.Neuroprotection in brain ischemia-doubts and hopes.Ideggyogy Sz,2004,57(3-4):81-93.
8Kennedy C,Grave GD,Jehle JW,et al.The effect of diphenylhydantion on local cerebral blood flow.Neurology,1972,22:451.
9Ragsdale DS,Avoli M.Sodium channels as molecular targets for anti-epilepticdrugs.Brain Res Rev,1998,26:16-28.
10Probert AW.Sodium channel modulators prevent oxygen and glucose deprivation injury and glutamate release in rat cortical cultures.Neuropharm,1997,36(8):1031.
